Zurcher-Kantonalbank-Zurich-Cantonalbank

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-07
Total Holdings
2,627
Total Value
34828700937
Accession Number
0000947871-25-000457
Form Type
13F-HR
Manager Name
Zurcher-Kantonalbank-Zurich-Cantonalbank
Data Enrichment
94% identified
2,475 identified152 unidentified

Holdings

2,627 positions • $34.8B total value
Manager:
Search and click to pin securities to the top
PLIANT THERAPEUTICS, INC.
Shares:9.0K
Value:$12.1K
% of Portfolio:0.0% ($12.1K/$34.8B)
LENZ Therapeutics, Inc.
Shares:460
Value:$11.8K
% of Portfolio:0.0% ($11.8K/$34.8B)
Inhibrx Biosciences, Inc.
Shares:824
Value:$11.5K
% of Portfolio:0.0% ($11.5K/$34.8B)
GALAPAGOS NV
Shares:455
Value:$11.4K
% of Portfolio:0.0% ($11.4K/$34.8B)
OMEROS CORP
Shares:1.4K
Value:$11.2K
% of Portfolio:0.0% ($11.2K/$34.8B)
Amylyx Pharmaceuticals, Inc.
Shares:3.2K
Value:$11.2K
% of Portfolio:0.0% ($11.2K/$34.8B)
REGENXBIO Inc.
Shares:1.6K
Value:$11.1K
% of Portfolio:0.0% ($11.1K/$34.8B)
ASTRAZENECA PLC
Shares:150
Value:$11.0K
% of Portfolio:0.0% ($11.0K/$34.8B)
488445206
Shares:1.5K
Value:$11.0K
% of Portfolio:0.0% ($11.0K/$34.8B)
Centessa Pharmaceuticals plc
Shares:755
Value:$10.9K
% of Portfolio:0.0% ($10.9K/$34.8B)
Limoneira CO
Shares:571
Value:$10.1K
% of Portfolio:0.0% ($10.1K/$34.8B)
Alvotech
Shares:1.0K
Value:$9.9K
% of Portfolio:0.0% ($9.9K/$34.8B)
Cartesian Therapeutics, Inc.
Shares:712
Value:$9.4K
% of Portfolio:0.0% ($9.4K/$34.8B)
AbCellera Biologics Inc.
Shares:4.2K
Value:$9.4K
% of Portfolio:0.0% ($9.4K/$34.8B)
MAXCYTE, INC.
Shares:3.3K
Value:$9.0K
% of Portfolio:0.0% ($9.0K/$34.8B)
Esperion Therapeutics, Inc.
Shares:6.1K
Value:$8.8K
% of Portfolio:0.0% ($8.8K/$34.8B)
Monte Rosa Therapeutics, Inc.
Shares:1.9K
Value:$8.6K
% of Portfolio:0.0% ($8.6K/$34.8B)
ArriVent BioPharma, Inc.
Shares:457
Value:$8.4K
% of Portfolio:0.0% ($8.4K/$34.8B)
Design Therapeutics, Inc.
Shares:2.2K
Value:$8.4K
% of Portfolio:0.0% ($8.4K/$34.8B)
Alpha Teknova, Inc.
Shares:1.6K
Value:$8.3K
% of Portfolio:0.0% ($8.3K/$34.8B)